Annual Financials for Community Health Systems Inc.
Fiscal year is January-December. All values USD millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Sales/Revenue
|
14.16B | 13.21B | 11.79B | 12.37B | 12.21B | |
Sales Growth |
- | -6.68% | -10.76% | 4.91% | -1.27% | |
Cost of Goods Sold (COGS) incl. D&A |
13.27B | 12.31B | 11.21B | 11.09B | 11.48B | |
COGS excluding D&A |
12.57B | 11.7B | 10.65B | 10.55B | 10.95B | |
Depreciation & Amortization Expense |
700M | 608M | 558M | 540M | 534M | |
Depreciation |
557M | 486M | 434M | 431M | 448M | |
Amortization of Intangibles |
143M | 122M | 124M | 109M | 86M | |
COGS Growth |
- | -7.25% | -8.90% | -1.12% | 3.58% | |
Gross Income |
886M | 903M | 577M | 1.28B | 728M | |
Gross Income Growth |
- | 1.92% | -36.10% | 122.18% | -43.21% | |
Gross Profit Margin |
- | - | - | - | 5.96% | NA |
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
SG&A Expense |
- | - | - | - | - | |
Research & Development |
- | - | - | - | - | |
Other SG&A |
- | - | - | - | - | |
SGA Growth |
- | - | - | - | - | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
651M | 308M | (866M) | (41M) | (346M) | |
EBIT after Unusual Expense |
235M | 595M | 1.44B | 1.32B | 1.07B | |
Non Operating Income/Expense |
6M | 4M | 2M | 39M | 119M | |
Non-Operating Interest Income |
7M | 3M | 3M | 3M | 2M | |
Equity in Affiliates (Pretax) |
22M | 15M | 10M | 22M | 14M | |
Interest Expense |
985M | 1.05B | 1.04B | 888M | 860M | |
Interest Expense Growth |
- | 6.29% | -1.05% | -14.29% | -3.15% | |
Gross Interest Expense |
1B | 1.07B | 1.05B | 901M | 869M | |
Interest Capitalized |
15M | 20M | 15M | 13M | 9M | |
Pretax Income |
(715M) | (430M) | 422M | 499M | 349M | |
Pretax Income Growth |
- | 39.86% | 198.14% | 18.25% | -30.06% | |
Pretax Margin |
- | - | - | - | 2.86% | NA |
Income Tax |
(11M) | 160M | (185M) | 131M | 170M | |
Income Tax - Current Domestic |
(8M) | (43M) | 2M | (40M) | 5M | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
(3M) | 203M | (187M) | 171M | 165M | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(704M) | (590M) | 607M | 368M | 179M | |
Minority Interest Expense |
84M | 85M | 96M | 138M | 133M | |
Net Income |
(788M) | (675M) | 511M | 230M | 46M | |
Net Income Growth |
- | 14.34% | 175.70% | -54.99% | -80.00% | |
Net Margin Growth |
- | - | - | - | 0.38% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
(788M) | (675M) | 511M | 230M | 46M | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
(788M) | (675M) | 511M | 230M | 46M | |
EPS (Basic) |
(6.99) | (5.93) | 4.42 | 1.81 | 0.36 | |
EPS (Basic) Growth |
- | 15.10% | 174.56% | -58.99% | -80.32% | |
Basic Shares Outstanding |
112.73M | 113.74M | 115.49M | 126.75M | 128.81M | |
EPS (Diluted) |
(6.99) | (5.93) | 4.38 | 1.76 | 0.35 | |
EPS (Diluted) Growth |
- | 15.10% | 173.88% | -59.83% | -79.92% | |
Diluted Shares Outstanding |
112.73M | 113.74M | 116.54M | 130.6M | 130.06M | |
EBITDA |
1.59B | 1.51B | 1.14B | 1.82B | 1.26B | |
EBITDA Growth |
- | -4.73% | -24.88% | 60.53% | -30.74% | |
EBITDA Margin |
- | - | - | - | 10.33% | NA |